Click and drag to rotate
Antibody FAB Antidote for Dabigatran and Base 4JN2 3d printed

DIGITAL PREVIEW
Not a Photo

Glossy Full Color Sandstone
Antibody FAB Antidote for Dabigatran and Base 4JN2 3d printed
Antibody FAB Antidote for Dabigatran and Base 4JN2 3d printed

DIGITAL PREVIEW
Not a Photo

Antibody FAB Antidote for Dabigatran and Base 4JN2

Made by
Print With Shapeways
Choose Your Size
$0.00
Choose Your Material
Choose your color and finish
QTY

Have a question about this product?

contact the designer
You must be logged in and verified to contact the designer.
Product Description
Dabigatran etexilate is a direct thrombin inhibitor and used widely as an anticoagulant for the prevention of stroke in patients with atrial fibrillation. However, anticoagulation therapy can be associated with an increased risk of bleeding. Here, we present data on the identification, humanization, and in vitro pharmacology of an antidote for dabigatran (aDabi-Fab). The X-ray crystal structure of dabigatran in complex with the antidote reveals many structural similarities of dabigatran recognition compared with thrombin. By a tighter network of interactions, the antidote achieves an affinity for dabigatran that is ~350 times stronger than its affinity for thrombin. Despite the structural similarities in the mode of dabigatran binding, the antidote does not bind known thrombin substrates and has no activity in coagulation tests or platelet aggregation. In addition we demonstrate that the antidote rapidly reversed the anticoagulant activity of dabigatran in vivo in a rat model of anticoagulation. This is the first report of a specific antidote for a next-generation
Details
What's in the box:
mdm_antibodyFAB_4JN2_atoms_ml_G34
Dimensions:
0 x 0 x 0 cm
Switch to inches
0 x 0 x 0 inches
Switch to cm
Success Rate:
First To try.
What's this?
Rating:
Mature audiences only.
Logo

Hello.

We're sorry to inform you that we no longer support this browser and can't confirm that everything will work as expected. For the best Shapeways experience, please use one of the following browsers:

Click anywhere outside this window to continue.